Tuesday, 18 August 2026
Palona AI introduced its multimodal AI operating layer for physical businesses, proven first in restaurants. Palona works with operators including Din Tai Fung, Mountain Mike's Pizza, Giordano's, Rooted Hospitality and Cali BBQ to connect customer demand, live operations and intelligent action. Palona closed its Series A financing, bringing total funding to $20 million, including conver
Cerbo, a leading electronic health record (EHR) platform for independent practices, announced the launch of AI Scribe, a clinical documentation tool built directly into the Cerbo EHR. Cerbo AI Scribe listens to the patient encounter, interprets the clinical conversation, and generates a structured note inside the chart, ready for the practitioner to review, edit, and sign. AI Scribe gives time ba
PointClickCare, a leading health tech company helping providers deliver exceptional care, announced the limited availability launch of Vox Advantage, the first AI-powered, voice-enabled documentation solution built natively into the industry's most widely-used Senior Care EHR. Designed specifically for the unique complexities of post-acute and senior living care settings, Vox Advantage captures ca
Ensora Health, the software and services company purpose-built for practice success across the full spectrum of therapy, launched Ensai℠ (EN-sigh), Ensora's AI. Ensai is a single intelligence available to more than 200,000 providers across five therapy disciplines: mental health, behavioral health, speech-language pathology, physical therapy, and occupational therapy. Ensai Support, the free in-
RecovryAI, a clinical AI company developing patient-facing Virtual Care Assistants (VCAs) for postoperative recovery, announced that its prospective pivotal study has reached last patient out, marking the completion of patient participation and clinical data collection. The 15-month study was conducted under institutional review board oversight at three U.S. orthopedic centers: OrthoArizona in Sc
Doctronic announced its expansion into pediatric primary care, marking the next step in its mission to build a comprehensive AI-native primary care platform. To accelerate that vision, the company has acquired Summer Health, the leading platform for virtual, text-based pediatric care. The expansion reflects a broader shift in healthcare: patients increasingly expect immediate, continuous access t
Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, announced that its FDA-cleared platform, Unfold AI, is now in use across the entire prostate cancer care continuum, including active surveillance, focal therapy, surgery, and radiotherapy. Unfold AI combines MRI, pathology, biomarkers, and clinical data to create personalized 3D prostate cancer maps t
SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and treated, announced a strategic partnership with Ferrum Health to make its FDA-cleared TumorSight® Viz platform available through Ferrum's Model Hub. The collaboration enables health systems nationwide to more seamlessly deploy, manage, and scale surgical planning capabilities within a trus
Brado AI, a healthcare engagement and technology company, announced it has joined Coalition for Health AI (CHAI) to accelerate the development of clinically governed, provider-anchored AI that supports responsible patient access and care navigation. CHAI is the leading coalition driving responsible AI adoption in the health sector and setting the gold standard for AI best practices. The organizat
Burtran, an innovator in wellness technology, announced the launch of Recharge™ Mask, a new AI-powered recovery wearable designed to help users make the most of 20- to 60-minute rest sessions. Available now on Burtran.com and Amazon, Recharge™ Mask combines EEG sensing, AI-guided personalization, immersive Bluetooth audio, binaural beats, gentle warming th
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced that it has entered into a definitive agreement to be acquired by Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care. The acquisition will expand Tempus capabilities in minimal residual disease (MRD) and enhance its ability
HealthTrust Performance Group™ (HealthTrust) announced the launch of Signal, an AI-powered intelligence platform that continuously synthesizes data from multiple sources—with the goal of empowering healthcare leaders to uncover opportunities, identify risks and take informed, measurable actions quickly. Healthcare organizations are managing an increasing volume of data across fragment
Coalition for Health AI (CHAI), a nonprofit organization founded by clinicians to advance responsible health AI, announced the launch of PULSE (Public health Use case and Learning Scaling Engine), a national initiative designed to help state, tribal, local, and territorial public health agencies responsibly evaluate, implement and scale generative AI. As part of this initiative, OpenAI and Anthrop
CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, announced the launch of its Global Digital Pathology and AI Consortium, a curated ecosystem of leading digital pathology, artificial intelligence and precision diagnostics innovators designed to help biopharma sponsors accelerate biomarker discovery, patient stratification, clinical trial execution and companion diagnost
WebPT, the leading rehab therapy platform designed to help practices improve efficiency, grow revenue, and manage every aspect of their business, announced the next generation of its Revenue Cycle Management (RCM) Services, combining the industry's most advanced AI-powered billing technology with the nation's largest team of rehab-specialized billing experts. As reimbursement grows more com
PTC (NASDAQ: PTC) announced the Onshape Labs™ initiative, a new early-access program within its Onshape® cloud-native CAD and PDM platform that gives participating customers a first look at emerging functionalities, including new uses of AI, delivered directly inside the product development workflow. Broader availability is expected later this summer, when users
Filevine, the leading platform for legal teams to manage case files in one integrated system, announced a strategic partnership with Codes Health, a transformative new category of AI-native medical record retrieval designed specifically for law firms. This goes beyond a standard third-party integration; it embeds a premium service that matches the high standards Filevine users expect. "Medic
Qtis.ai, an applied artificial intelligence company focused on healthcare, medical research, and aesthetics, announced the launch of its Clinical Research Division and the commercial deployment of its AI-native Clinical Trial Management System (CTMS), a next-generation platform designed specifically for the AI era. The company also announced its first CTMS customer, Cardiac Dimensions, Inc. (CDI)
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced the creation of Orphia™, a new AI-powered digital health platform built on the belief that eye care providers should spend less time managing disconnected tools and technologies and more time caring for patients. The platform is brand agnostic and d
CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced the integration of the ArteraAI Prostate Test into its diagnostic workflows, becoming the first laboratory in Puerto Rico to bring this guideline-recommended AI test into routine clinical use, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate Test is an
OpenEvidence and the Anticoagulation Forum (AC Forum) announced a strategic partnership to provide antithrombotic guidance and tools that support decision-making in clinical practice. By combining the AC Forum’s leadership in education and multidisciplinary clinical guidance with OpenEvidence’s advanced artificial intelligence platform, clinicians will gain access to timely and practic
Altasciences, a fully integrated early-phase drug development organization, and Evidence Matters, a pioneer in clinical trial data science, are pleased to announce a successful proof-of-concept (POC) of RegulatoryFlow (“RegFlow”), following the announcement of the companies’ strategic collaboration in August 2025. The POC demonstrated the extension of AI-driven efficien
